Skip to main content

Table 2 Outcomes of the clinical trials included in the meta-analysis

From: The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis

Study Sample size (n) HCV genotype (n) End of treatment End of follow-up
     HCV ETVR (n) ALT normalization (n) HCV SVR (n) HCV relapse (n) ALT normalization (n)
   Genotype 1 Non- genotype 1 Overall Genotype 1 Non-genotype 1   Overall Genotype 1 Non-genotype 1 Overall Genotype 1 Non-genotype 1  
Yu et al. [35] C: 50 30 20 46 27 19 NR 27 12 15 19 15 4 NR
  M: 46 25 21 32 14 18 NR 26 11 15 6 3 3 NR
Liu et al. [32] C: 161 97 64 138 82 56 NR 123 70 53 15 12 3 103
  M: 160 110 50 141 95 46 NR 127 85 42 14 10 4 122
Chuang et al. [34] C: 42 21 21 NR NR NR NR 29 10 19 NR NR NR 23
  M: 84 48 36 NR NR NR NR 54 39 15 NR NR NR 51
Hung et al. [30] C: 36 17 19 33 NR NR 24 25 10 15 8 NR NR 20
  M: 72 34 38 68 NR NR 66 51 18 33 17 NR NR 52
Liu et al. [36] C: 24 14 7 16 10 6 12 9 3 6 7 NR NR 9
  M: 30 17 13 25 NR NR 23 18 NR NR 5 NR NR 18
  1. C HBV and HCV coinfection, M HCV mono-infection, NR not reported.